News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



REFILE-Predicted albumin-creatinine ratio performs well for CKD screening, staging and prognosis

(In para 3, changes CSK to CKD, in story originally published July 13.) By Megan Brooks (Reuters Health) - Researchers with the Chronic Kidney Disease Prognosis Consortium have developed equations to

Brain-computer interface training reduces phantom-limb pain

By Will Boggs MD NEW YORK (Reuters Health) - Brain-computer interface (BCI) to control an image of a phantom hand reduces phantom-limb pain, according to results from a crossover trial. "BCI training

UPDATE 1-Second COVID wave 'highly likely' to hit France this year, scientists say

(Adds Paris considering making masks compulsory, Macron quote) By Reuters Staff PARIS (Reuters) - A second wave of the coronavirus epidemic is highly likely to hit France in the autumn or winter, the

UPDATE 1-UK risks twice-as-big second COVID wave without better testing, study finds

(Adds details, further government comment) By Reuters Staff LONDON (Reuters) - Britain risks a second wave of COVID-19 this winter twice as large as the initial outbreak if it reopens schools

Radiotherapy improves overall survival in metastatic nasopharyngeal carcinoma

By Will Boggs MD NEW YORK (Reuters Health) - Locoregional radiotherapy added to chemotherapy improves overall survival in patients with de novo metastatic nasopharyngeal carcinoma (mNPC), according to

Acetaminophen use linked to false-positive test for chronic granulomatous disease

By Anne Harding NEW YORK (Reuters Health) - Recent acetaminophen use can lead to a false positive result on the dihydrorhodamine (DHR) test, new findings show. "Taking acetaminophen may affect the

Rosuvastatin myotoxicity can emerge after initiating canagliflozin

By Reuters Staff NEW YORK (Reuters Health) - Rosuvastatin myotoxicity can develop after initiation of treatment with canagliflozin, a sodium-glucose cotransporter-2 inhibitor, according to a new case

What to do about interference between maternal pertussis vaccination, infant's DTwP shot

By Reuters Staff NEW YORK (Reuters Health) - Health providers should pay extra attention to infants with signs of pertussis given the potential interaction between maternal vaccination for the disease

Jury out on how best to screen for health-related social needs

By Megan Brooks NEW YORK (Reuters Health) - Screening for health-related social needs, such as housing, food and transportation problems, are increasingly being incorporated into clinical care but the

SPECIAL REPORT-Local governments 'overwhelmed' in race to trace U.S. COVID contacts

By Benjamin Lesser, Dan Levine, Jaimi Dowdell and Andrea Januta (Reuters) - The soaring number of COVID-19 cases in the United States has far outstripped many local health departments' ability to

Prenatal flu vaccine not linked to adverse early childhood outcomes

By Lisa Rapaport (Reuters Health) - In utero exposure to influenza vaccines doesn't appear to contribute to mortality, morbidity or adverse health outcomes in children under five years of age, a

Low-dose antihypertensive combo improves blood pressure control

By Will Boggs MD NEW YORK (Reuters Health) - A low-dose fixed-dose combination of three antihypertensive drugs improves blood pressure control but is associated with greater rates of therapeutic

Sentinel lymph node biopsy holds promise in periocular cancer

By David Douglas NEW YORK (Reuters Health) - Sentinel lymph node biopsy (SLNB) can provide tumor-staging information in patients with malignancies of the conjunctiva and eyelid, but whether SLNB leads

UK risks twice-as-big second COVID wave without better testing, study finds

By Reuters Staff LONDON (Reuters) - Britain faces a second wave of COVID-19 this winter twice as widespread as the initial outbreak if it reopens schools without a more effective test-and-trace system

Taiwan provisionally approves dexamethasone as coronavirus treatment

By Reuters Staff TAIPEI (Reuters) - Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the

Abiomed heart pump gets second FDA emergency use nod for COVID-19 patients

By Reuters Staff (Reuters) - Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients

WHO says China team interviewed Wuhan scientists over virus origins

By Reuters Staff GENEVA (Reuters) - A World Health Organization team in China to probe the origins of COVID-19 had "extensive discussions" and exchanges with scientists in Wuhan where the outbreak was

FEATURE-Military helps worn-out nurses, sicker patients in California COVID-19 effort

By Sharon Bernstein SACRAMENTO, Calif. (Reuters) - All day long, as Air Force nurse Major Pinky Brewton cares for patients struggling to breathe in California's COVID-19 ravaged San Joaquin Valley,

Germany already dealing with second coronavirus wave - doctors' union

By Reuters Staff BERLIN (Reuters) - Germany is already contending with a second wave of the coronavirus and risks squandering its early success by flouting social distancing rules, the head of the

Second COVID wave 'highly likely' to hit France this year, scientists say

By Reuters Staff PARIS (Reuters) - A second wave of the coronavirus epidemic is "highly likely" to hit France in the autumn or winter, the government's top scientific body warned on Tuesday, as

Curevac names Franz-Werner Haas as CEO

BERLIN, Aug 4 (Reuters) - German biotech firm CureVac on Tuesday appointed acting Chief Executive Officer and Chief Operating Officer (COO) Franz-Werner Haas CEO, with former CEO and co-founder Ingmar

Stress cardiac MRI can help guide decision making for patients with cardiovascular risk

By Marilynn Larkin NEW YORK (Reuters Health) - In symptomatic patients without a history of coronary artery disease (CAD), stress cardiac magnetic resonance (CMR) imaging can reclassify risk, thereby

Multidisciplinary approach bests specialist care for functional GI problems

By Marilynn Larkin NEW YORK (Reuters Health) - For patients with irritable bowel syndrome and other functional gastrointestinal disorders, a multidisciplinary team approach was more effective and less

Some seniors may be left behind as telemedicine becomes more popular

By Linda Carroll (Reuters Health) - Seniors may be left behind in the rush to adopt telemedicine, some because they don't have the equipment or access to the internet, others because disabilities make

Interleukin-1-beta blockade may slow progression of osteoarthritis

By Reuters Staff NEW YORK (Reuters Health) - Interleukin-1-beta is a key player in the osteoarthritis inflammatory process and inhibiting it may help slow the disease process, according to an

UPDATE 1-Eli Lilly tests antibody drug to halt COVID-19 spread in U.S. nursing homes

(Adds details from interview with chief scientific officer) By Michael Erman and Carl O'Donnell (Reuters) - Eli Lilly & Co said on Monday it started a late-stage trial testing whether one of its

Group pelvic floor-muscle training for urinary incontinence noninferior to individual sessions

By Lisa Rappaport (Reuters Health) - Older women with urinary incontinence may experience a similar reduction in episodes with group pelvic floor muscle training compared with one-on-one sessions, a

Italy survey suggests coronavirus six times more prevalent than official data

By Reuters Staff MILAN (Reuters) - Almost 1.5 million people in Italy or 2.5% of the population have developed coronavirus antibodies, a figure six times more than official numbers reported, according

Many older U.S. adults get cancer screenings beyond recommended ages

By Lisa Rappaport (Reuters Health) - More than half of U.S. adults who are past the recommended age for colorectal cancer screenings get them anyway, and so do roughly three in four women too old for

COVID SCIENCE-Engineered decoys trap virus in test tube study; healthcare workers at high risk even with protections

By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness

Thousands march in Berlin against coronavirus curbs

By Reuters Staff BERLIN (Reuters) - Thousands marched in Berlin on Saturday to protest against measures imposed in Germany to stem the coronavirus pandemic, saying they violated people's rights and

REFILE-Some COVID-19 survivors suffer psychiatric disorders, Italian study says

(Revises topic codes, no change to article text) By Emilio Parodi MILAN (Reuters) - COVID-19 survivors suffer higher rates of psychiatric disorders including post-traumatic stress (PTSD), anxiety,

Some COVID-19 survivors suffer psychiatric disorders, Italian study says

By Emilio Parodi MILAN (Reuters) - COVID-19 survivors suffer higher rates of psychiatric disorders including post-traumatic stress (PTSD), anxiety, insomnia and depression, according to a study

Sanofi formally investigated over epilepsy drug Depakine

By Reuters Staff PARIS (Reuters) - Healthcare company Sanofi Aventis France said it had been placed under formal investigation on charges of manslaughter over Depakine, which is an epilepsy drug that

Rival drugmakers launch joint trial of medicines for COVID-19

By Deena Beasley (Reuters) - Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each

Neutralizing antibodies protect against enterovirus D68

By Will Boggs MD NEW YORK (Reuters Health) - Antibodies from previously infected individuals can neutralize enterovirus D68 (EV-D68), the putative cause of acute flaccid myelitis (AFM) outbreaks, and

Radial-artery diameters in many children could support transradial interventions

By Will Boggs MD NEW YORK (Reuters Health) - Many children have radial arteries large enough for transradial interventions, researchers report. "The most interesting finding from this study, which

Adjuvant systemic chemotherapy tied to better survival after resection of colorectal peritoneal metastases

By Will Boggs MD NEW YORK (Reuters Health) - Adjuvant systemic chemotherapy following resection of isolated synchronous colorectal peritoneal metastases is associated with improved survival compared

Spain to roll out COVID-19 app twice as effective as human tracers in pilot

By Isla Binnie MADRID (Reuters) - Spain aims to roll out a COVID-19 contact-tracing app across the country in September after saying on Monday that a pilot showed it could detect almost twice as many

Most Brits, French, Germans would skip holiday if tests, masks involved - survey

By Reuters Staff LISBON (Reuters) - As new coronavirus travel restrictions kick in across Europe, a survey showed at least half of German, British and French travellers would rather cancel a holiday

Vietnam says early August 'decisive' in containing coronavirus

By Khanh Vu and Phuong Nguyen HANOI (Reuters) - Vietnam is in the midst of a "decisive" fight against the novel coronavirus, its premier said on Monday, focusing on the city of Danang where infections

Anxious WHO implores world to 'do it all' in long war on COVID-19

By Michael Shields and Emma Farge GENEVA (Reuters) - The World Health Organization warned on Monday that there might never be a "silver bullet" for COVID-19 in the form of a perfect vaccine and that

INSIGHT-Long-term complications of COVID-19 signals billions in healthcare costs ahead

By Caroline Humer, Nick Brown and Emilio Parodi NEW YORK (Reuters) - Late in March, Laura Gross, 72, was recovering from gall bladder surgery in her Fort Lee, New Jersey, home when she became sick

FOCUS-Next big COVID-19 treatment may be manufactured antibodies

By Deena Beasley (Reuters) - As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other

Eli Lilly starts late-stage study of COVID-19 drug in nursing homes

By Michael Erman (Reuters) - U.S. drugmaker Eli Lilly & Co is beginning a late-stage trial to study whether one of its experimental COVID-19 antibody treatments can prevent the spread of the virus in

Coronavirus spread among children in Georgia youth camp, CDC says

By Manojna Maddipatla (Reuters) - The coronavirus spread to at least 44% of staff and campers at a sleep-away camp in Georgia over a week and a half, the U.S. Centers for Disease Control said. "This

Life-prolonging cancer treatments should continue: ESMO

By Reuters Staff (Reuters Health) - In most cases, cancer treatment that improves a patient's odds of survival should not be stopped or delayed during the coronavirus pandemic, according to guidelines

Nivolumab plus ipilimumab or pembrolizumab most cost-effective for newly diagnosed advanced melanoma

By Marilynn Larkin NEW YORK (Reuters Health) - First-line treatment with nivolumab plus ipilimumab or pembrolizumab were the more cost-effective options for newly diagnosed advanced melanoma with

Computer model suggests safe path to bringing college kids back to campus

By Linda Carroll (Reuters Health) - Frequent SARS-CoV-2 testing, as often as every other day, coupled with strict adherence to prevention guidelines, might allow college students to safely return to

Florida sets new coronavirus record as U.S. lawmakers bicker at hearing

By Maria Caspani and David Morgan (Reuters) - Florida, one of the U.S. coronavirus hotspots, reported another record increase in COVID-19 deaths on Friday as the country's top infectious disease

UPDATE 1-U.S. to pay $2.1 bln to Sanofi, GSK, in COVID-19 vaccine deal

(Adds company confirmation of supply talks with EU) By Michael Erman and Carl O'Donnell July 31 (Reuters) - The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19

COVID SCIENCE-Small children carry high amounts of virus; safely opening colleges will be a challenge

By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness

France readies COVID tests for travellers from at-risk countries

By Emilie Delwarde PARIS (Reuters) - France's busiest airport was on Friday preparing to start testing passengers for COVID-19 on arrival from high-risk countries, a move that could reduce the need

Google says 20 U.S. states, territories 'exploring' contact tracing apps

By Paresh Dave OAKLAND, Calif. (Reuters) - Alphabet Inc's Google said on Friday that 20 U.S. states and territories, representing about 45% of the country's population, are "exploring" contact tracing

Canada launches COVID-19 contact tracing app as restrictions loosen

By Kelsey Johnson OTTAWA (Reuters) - Canada on Friday launched a nation-wide contact tracing app to help inform Canadians when they may have been exposed to the coronavirus, part of a broader effort

U.S. chemical safety watchdog to proceed, with only one board member

By Erwin Seba HOUSTON (Reuters) - The U.S. Chemical Safety Board, which has only one board member instead of the usual five, was to meet on Friday despite efforts by President Donald Trump to wind

Trump administration can cut drug subsidies to hospitals - U.S. court

By Nate Raymond (Reuters) - A divided U.S. appeals court on Friday ruled the Trump administration had the authority to reduce subsidies Medicare pays certain hospitals to obtain discounted

Hypertension undertreated in people with history of stroke

By Lisa Rappaport (Reuters Health) - Many U.S. adults with a history of stroke have hypertension but are unaware of their condition or are not receiving treatment for it, a recent study suggests.

UPDATE 1-Partisan clash at start of U.S. House coronavirus hearing with Fauci

(Recasts with Fauci testimony) By David Morgan WASHINGTON (Reuters) - Top U.S. infectious disease expert Dr. Anthony Fauci on Friday resisted efforts by a staunch ally of President Donald Trump to

Under pressure, Spanish family doctors battle the coronavirus

By Elena Rodriguez and Raul Cadenas MADRID (Reuters) - Spain's family doctors are feeling the strain as they increasingly take the place of emergency and intensive-care colleagues on the front lines

NIH investing $248.7 mln in seven companies to scale up COVID-19 testing

By Reuters Staff (Reuters) - The National Institutes of Health (NIH) said on Friday it is investing $248.7 million in seven diagnostic companies with new testing technologies to increase their testing

SAP, Deutsche Telekom to build corona app gateway for European Commission

By Douglas Busvine BERLIN (Reuters) - The European Commission said on Friday it had signed a contract for SAP and Deutsche Telekom to build a software platform that would enable national coronavirus

No increase in congenital heart disease after Fukushima nuclear accident

By Reuters Staff NEW YORK (Reuters Health) - First-time surgeries for congenital heart disease did not increase following the 2011 Fukushima nuclear accident, researchers in Japan report. In 2019, Dr.

Sevoflurane shows promise as topical analgesic for intractable pain

By Scott Baltic NEW YORK (Reuters Health) - The widely used inhalational anesthetic sevoflurane was effective as a topical analgesic in treating otherwise refractory pain in an elderly patient with a

Antivenom-anticholinesterase combination reverses cobra snakebite mimicking brain death

By Reuters Staff NEW YORK (Reuters Health) - A combination of polyvalent snake antivenom (PSA) and anticholinesterase successfully reversed cobra snakebite mimicking brain death in a 57-year-old woman

Neoadjuvant chemoradiotherapy best restricted to high-risk rectal cancer patients

By David Douglas NEW YORK (Reuters Health) - Because neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer carries a high risk of adverse effects, careful selection is needed to avoid

Better COVID-19 outcomes seen with continued ACE inhibitor, ARB use

By Will Boggs MD NEW YORK (Reuters Health) - Hospitalized COVID-19 patients with high blood pressure who continue on angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (

Telemedicine helps but also highlights health disparities during pandemic

By Carolyn Crist NEW YORK (Reuters Health) - The COVID-19 pandemic has accelerated the expansion of telemedicine across the U.S., which has opened up access to doctor's offices for families with

Cancer patients with COVID-19 don't appear to be at higher risk for blood clots

By Megan Brooks NEW YORK (Reuters Health) - Patients with cancer and COVID-19 who are in remission or not on active cancer therapy do not appear to be at increased risk of developing blood clots or

Seasonal flu reports hit record lows amid global social distancing

By Cate Cadell BEIJING (Reuters) - Global social distancing rules targeting coronavirus have pushed influenza infection rates to a record low, early figures show, signalling that the measures are

Children carry COVID-19 virus, small study finds

By Reuters Staff (Reuters) - Children younger than five carried major amounts of coronavirus in their upper respiratory tract, a small study published on Thursday showed, raising new questions about

Itolizumab lowers risk of death in elderly COVID-19 patients -Cuban study

By Vishwadha Chander (Reuters) - An antibody drug already being used against the coronavirus in Cuba decreased the risk of intensive care admission and death among nursing home residents with moderate

Large U.S. COVID-19 vaccine trials will exclude pregnant women for now

By Julie Steenhuysen CHICAGO (Reuters) - The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable

U.S. government to launch 'overwhelming' COVID-19 vaccine campaign by November

By Carl O'Donnell (Reuters) - The Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent

U.S. to pay $2.1 bln to Sanofi, GSK, in COVID-19 vaccine deal

By Michael Erman and Carl O'Donnell (Reuters) - The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the

EXCLUSIVE-China-backed hackers 'targeted COVID-19 vaccine firm Moderna'

By Christopher Bing and Marisa Taylor WASHINGTON (Reuters) - Chinese government-linked hackers targeted biotech company Moderna Inc, a U.S.-based coronavirus vaccine research developer, this year in a

Trump planning for U.S. rollout of coronavirus vaccine falling short, officials warn

By Richard Cowan WASHINGTON (Reuters) - As scientists and pharmaceutical companies work at breakneck speed to develop a vaccine for the novel coronavirus, public health officials and senior U.S.

Partisan clash at start of U.S. House coronavirus hearing with Fauci

By David Morgan WASHINGTON (Reuters) - Congressional Republicans and Democrats clashed about whether the Trump administration had a national strategy to respond to the coronavirus pandemic at the

Severe hearing loss from ototoxic cancer therapies in childhood tied to neurocognitive deficits

By Linda Carroll (Reuters Health) - Severe hearing impairment in childhood cancer survivors is associated with neurocognitive deficits, a new study suggests. An analysis of data from more than 1,500

U.S. hip fracture incidence declines with reductions in smoking, drinking

By Lisa Rapaport (Reuters Health) - Age-adjusted hip fracture incidence has declined in the U.S. over the past four decades, aided by a decline in smoking and alcohol consumption, a new study suggests

CT imaging finds no sinus changes in COVID-19 anosmia

By Marilynn Larkin NEW YORK (Reuters Health) - No significant mucosal changes or olfactory cleft abnormalities were found in a computed tomography (CT) imaging study of the paranasal sinuses of COVID-

A big obstacle: Where can CanSino test its vaccine abroad?

By Roxanne Liu and Miyoung Kim BEIJING/SINGAPORE (Reuters) - CanSino Biologics Inc, one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas

AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries

By Ludwig Burger and Pushkala Aripaka (Reuters) - AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with

J&J starts human study of COVID-19 vaccine after promising monkey data

By Julie Steenhuysen (Reuters) - Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its

Urodynamic studies don't reduce prostate-surgery rates

By Will Boggs MD NEW YORK (Reuters Health) - Urodynamic studies do not reduce prostate-surgery rates in men with lower-urinary-tract symptoms (LUTS), according to results from the UPSTREAM trial. "A

COVID-19 disrupting cancer care and clinical research

By Megan Brooks NEW YORK (Reuters Health) - The COVID-19 pandemic has had a huge impact on cancer care and research, according to research presented earlier this month during the American Association

Cancer patients still need human connection during COVID-19

By Carolyn Crist NEW YORK (Reuters Health) - As social-distancing guidelines continue during the pandemic, cancer patients need quality care and ongoing connection with others, oncologists say in a

After three decades, most polluted U.S. neighborhoods haven't changed

By Nichola Groom (Reuters) - If your neighborhood was among the most polluted in 1981, it probably still is. Likewise, the least polluted areas are still faring the best, according to a study

Surveillance scheme hunts for COVID traces in Israel's sewers

By Reuters Staff ASHKELON, Israel (Reuters) - Sewer surveillance in Israel's coastal city of Ashkelon has pinpointed unknown outbreaks of COVID-19 by identifying traces of the virus in the sewage

Brain-responsive neurostimulation shows real-world epilepsy benefit

By Anne Harding NEW YORK (Reuters Health) - Two new real-world studies confirm the benefits of brain-responsive neurostimulation for focal epilepsy. Patients' seizures were reduced by 75%, on average,

NYU launches coronavirus safety training for Uber, Lyft drivers as many return to work

By Tina Bellon NEW YORK (Reuters) - Public health researchers at New York University are launching a coronavirus safety training for ride-hail workers at a time when many Uber and Lyft drivers are

DPP-4 inhibitors may up risk of bullous pemphigoid in some diabetics

By David Douglas NEW YORK (Reuters Health) - In certain patients with type 2 diabetes, starting dipeptidyl peptidase 4 (DPP-4) inhibitors may increase the risk of developing bullous pemphigoid,

SARS-CoV-2 isolated from middle ear, mastoid bone

By Will Boggs MD NEW YORK (Reuters Health) - SARS-CoV-2 has been isolated from mastoid-bones and middle-ear autopsy specimens from two patients who died with COVID-19, which has implications for

Remdesivir therapy tied to lower mortality in severe COVID-19

By Will Boggs MD NEW YORK (Reuters Health) - Remdesivir treatment is associated with reduced odds of death and improved odds of recovery in patients with severe COVID-19, according to an interim

CORRECTED-Roche bid to retool arthritis drug for COVID-19 fails

(In JULY 29 story, corrects number of people in trial to 452, paragraph 2) By John Revill ZURICH (Reuters) - Roche's attempt to retool its rheumatoid arthritis drug Actemra/RoActemra to treat patients

Many patients with hyperparathyroidism going undiagnosed

By Linda Carroll (Reuters Health) - Many patients who have hyperparathyroidism may be missed because physicians aren't testing for it even when two indications for screening - a kidney stone and

Antibody treatment lowers risk of infant RSV; maternal vaccination test falls short

By Gene Emery (Reuters Health) - In the quest to control the respiratory syncytial virus (RSV) that plagues infants, an experimental single-dose monoclonal antibody treatment has shown promise in a

Myomectomy yields slightly better QOL than uterine-artery embolization

By Gene Emery NEW YORK (Reuters Health) - Women who undergo traditional fibroid-removal surgery report a marginally better two-year health-related quality of life than women treated with

Is TAS-118 plus oxaliplatin a new standard first-line therapy for advanced gastric cancer in Asians?

By Marilynn Larkin NEW YORK (Reuters Health) - TAS-118 (oral S-1 plus leucovorin) plus oxaliplatin was more effective than S-1 plus cisplatin in a phase III trial and could be considered a new

RNA-sequenced tape strips differentiate atopic dermatitis from psoriasis

By Marilynn Larkin NEW YORK (Reuters Health) - RNA-sequenced (RNA-seq) tape strip profiling distinguished atopic dermatitis (AD) from psoriasis, potentially offering a minimally invasive alternative

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information